KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Invested Capital (2016 - 2025)

Historic Invested Capital for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $53.3 billion.

  • Merck's Invested Capital rose 1174.41% to $53.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 billion, marking a year-over-year increase of 1174.41%. This contributed to the annual value of $49.0 billion for FY2024, which is 2567.23% up from last year.
  • As of Q3 2025, Merck's Invested Capital stood at $53.3 billion, which was up 1174.41% from $50.5 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Invested Capital registered a high of $53.3 billion during Q3 2025, and its lowest value of $34.3 billion during Q1 2021.
  • In the last 5 years, Merck's Invested Capital had a median value of $46.3 billion in 2022 and averaged $44.5 billion.
  • As far as peak fluctuations go, Merck's Invested Capital surged by 2904.73% in 2022, and later crashed by 1874.22% in 2023.
  • Quarter analysis of 5 years shows Merck's Invested Capital stood at $40.7 billion in 2021, then grew by 18.04% to $48.0 billion in 2022, then dropped by 18.74% to $39.0 billion in 2023, then grew by 25.67% to $49.0 billion in 2024, then grew by 8.75% to $53.3 billion in 2025.
  • Its last three reported values are $53.3 billion in Q3 2025, $50.5 billion for Q2 2025, and $49.8 billion during Q1 2025.